Neuberger Berman Group
ARRY

Neuberger Berman Group’s Array Biopharma Inc ARRY Stock Holding History

Neuberger Berman Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-306,225
Closed -$14.2M – 1642
2019
Q2 		$14.2M Sell
306,225
-90,450
-23% -$2.54M 0.02% 685
2019
Q1 		$9.67M Sell
396,675
-378,850
-49% -$7.89M 0.01% 749
2018
Q4 		$11.1M Sell
775,525
-10,000
-1% -$152K 0.02% 719
2018
Q3 		$11.9M Buy
785,525
+45,500
+6% +$697K 0.01% 762
2018
Q2 		$12.4M Sell
740,025
-70,700
-9% -$1.12M 0.01% 768
2018
Q1 		$13.2M Buy
810,725
+715,000
+747% +$11.5M 0.02% 723
2017
Q4 		$1.23M Buy
95,725
+32,725
+52% +$372K ﹤0.01% 1138
2017
Q3 		$775K Buy
+63,000
New +$585K ﹤0.01% 1209
2015
Q4 		– Sell
-24,610
Closed -$112K – 1602
2015
Q3 		$112K Sell
24,610
-680
-3% -$4.03K ﹤0.01% 1485
2015
Q2 		$182K Sell
25,290
-4,920
-16% -$36.3K ﹤0.01% 1506
2015
Q1 		$223K Buy
30,210
+820
+3% +$5.84K ﹤0.01% 1511
2014
Q4 		$139K Sell
29,390
-4,000
-12% -$15.8K ﹤0.01% 1595
2014
Q3 		$119K Buy
33,390
+15,480
+86% +$61K ﹤0.01% 1615
2014
Q2 		$82K Sell
17,910
-3,810
-18% -$15.8K ﹤0.01% 1686
2014
Q1 		$102K Buy
21,720
+2,450
+13% +$12.3K ﹤0.01% 1588
2013
Q4 		$97K Buy
19,270
+800
+4% +$4.36K ﹤0.01% 1587
2013
Q3 		$115K Buy
+18,470
New +$110K ﹤0.01% 1564

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Neuberger Berman Group's ARRY Position: Q3 2019 in Review

Neuberger Berman Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 306,225 shares — an estimated $14.2M sold.

Neuberger Berman Group first reported a position in ARRY in Q3 2013 and held it in 17 quarters. The position peaked at $14.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Neuberger Berman Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Neuberger Berman Group sold 306,225 Array Biopharma Inc shares in Q3 2019, an estimated $14.2M.
  • Neuberger Berman Group first reported a position in Array Biopharma Inc in Q3 2013 and held it in 17 quarters.
  • Neuberger Berman Group's Array Biopharma Inc position peaked at $14.2M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Neuberger Berman Group's 13F filing for Q3 2019, filed 13 Nov 2019.